Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle?

by Passiglia, Francesco, Novello, Silvia
Published in Ann Transl Med (2018)

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?

by Passiglia, Francesco, Novello, Silvia
Published in Transl Lung Cancer Res (2020)

Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure?

by Bironzo, Paolo, Passiglia, Francesco, Novello, Silvia
Published in Ann Transl Med (2019)

Moving osimertinib to first-line: the right “strategy” in the chessboard of epidermal growth factor receptor-mutated non-small cell lung cancer?

by Passiglia, Francesco, Raez, Luis E., Rolfo, Christian
Published in J Thorac Dis (2018)

First-line immune-chemotherapy combination: the right strategy to fight squamous non-small cell lung cancer?

by Passiglia, Francesco, Bironzo, Paolo, Scagliotti, Giorgio V.
Published in Transl Lung Cancer Res (2019)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

by Passiglia, Francesco, Reale, Maria Lucia, Cetoretta, Valeria, Novello, Silvia
Published in Immunotargets Ther (2021)

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience

by Capelletto, Enrica, Passiglia, Francesco, Ferraresi, Federica, Vallone, Stefania, Novello, Silvia
Published in J Thorac Dis (2020)

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review

by Leone, Gianmarco, Passiglia, Francesco, Bironzo, Paolo, Bertaglia, Valentina, Novello, Silvia
Published in Transl Lung Cancer Res (2020)

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease

by Passiglia, Francesco, Cetoretta, Valeria, De Filippis, Marco, Napoli, Valerio, Novello, Silvia
Published in Transl Lung Cancer Res (2021)

Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…

by Thungappa, Satheesh, Ferri, Jose, Caglevic, Christian, Passiglia, Francesco, Raez, Luis, Rolfo, Christian
Published in ESMO Open (2017)

Vaccine and immune cell therapy in non-small cell lung cancer

by Oliveres, Helena, Caglevic, Christian, Passiglia, Francesco, Taverna, Simona, Smits, Evelien, Rolfo, Christian
Published in J Thorac Dis (2018)

Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway

by La Paglia, Laura, Listì, Angela, Caruso, Stefano, Amodeo, Valeria, Passiglia, Francesco, Bazan, Viviana, Fanale, Daniele
Published in PPAR Res (2017)

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib

by Corrales, Luis, Nogueira, Amanda, Passiglia, Francesco, Listi, Angela, Caglevic, Christian, Giallombardo, Marco, Raez, Luis, Santos, Edgardo, Rolfo, Christian
Published in Front Med (Lausanne) (2017)

Multisciplinary management of patients with liver metastasis from colorectal cancer

by De Greef, Kathleen, Rolfo, Christian, Russo, Antonio, Chapelle, Thiery, Bronte, Giuseppe, Passiglia, Francesco, Coelho, Andreia, Papadimitriou, Konstantinos, Peeters, Marc
Published in World J Gastroenterol (2016)

Nintedanib in NSCLC: evidence to date and place in therapy

by Bronte, Giuseppe, Passiglia, Francesco, Galvano, Antonio, Barraco, Nadia, Listì, Angela, Castiglia, Marta, Rizzo, Sergio, Fiorentino, Eugenio, Bazan, Viviana, Russo, Antonio
Published in Ther Adv Med Oncol (2016)

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

by Passiglia, Francesco, Bronte, Giuseppe, Bazan, Viviana, Natoli, Clara, Rizzo, Sergio, Galvano, Antonio, Listì, Angela, Cicero, Giuseppe, Rolfo, Christian, Santini, Daniele, Russo, Antonio
Published in Oncotarget (2016)

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

by Passiglia, Francesco, Rizzo, Sergio, Di Maio, Massimo, Galvano, Antonio, Badalamenti, Giuseppe, Listì, Angela, Gulotta, Leonardo, Castiglia, Marta, Fulfaro, Fabio, Bazan, Viviana, Russo, Antonio
Published in Sci Rep (2018)

Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

by Passiglia, Francesco, Rizzo, Sergio, Di Maio, Massimo, Galvano, Antonio, Badalamenti, Giuseppe, Listì, Angela, Gulotta, Leonardo, Castiglia, Marta, Fulfaro, Fabio, Bazan, Viviana, Russo, Antonio
Published in Sci Rep (2018)

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

by Bronte, Giuseppe, Silvestris, Nicola, Castiglia, Marta, Galvano, Antonio, Passiglia, Francesco, Sortino, Giovanni, Cicero, Giuseppe, Rolfo, Christian, Peeters, Marc, Bazan, Viviana, Fanale, Daniele, Giordano, Antonio, Russo, Antonio
Published in Oncotarget (2015)

Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients

by Passiglia, Francesco, Galvano, Antonio, Castiglia, Marta, Incorvaia, Lorena, Calò, Valentina, Listì, Angela, Mazzarisi, Salvatore, Perez, Alessandro, Gallina, Giuseppe, Rizzo, Sergio, Soto Parra, Hector, Bazan, Viviana, Russo, Antonio
Published in Ther Adv Med Oncol (2019)